Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Chinese Patent Office
Medtronic
Cipla
Harvard Business School
UBS
Dow
Daiichi Sankyo
Argus Health

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,114,313

« Back to Dashboard

Which drugs does patent 6,114,313 protect, and when does it expire?

Patent 6,114,313 protects KENGREAL and is included in one NDA.

This patent has thirty-nine patent family members in thirty-two countries.
Summary for Patent: 6,114,313
Title: Pharmaceutical compositions for freeze drying
Abstract:A pharmaceutical composition comprising a nucleotide analogue, mannitol and a modifying additive which is sodium chloride or a polyol which is suitable for freeze drying.
Inventor(s): Bland; Chris (Leics, GB), Steele; Gerald (Leics, GB)
Assignee: Astra Zeneca UK Limited (London, GB)
Application Number:09/043,159
Patent Claim Types:
see list of patent claims
Composition; Compound; Process; Use;

Drugs Protected by US Patent 6,114,313

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Chiesi Usa Inc KENGREAL cangrelor POWDER;IV (INFUSION) 204958-001 Jun 22, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y P2Y12 PLATELET INHIBITOR FOR USE AS ADJUNCT TO PERCUTANEOUS CORONARY INTERVENTION TO REDUCE RISK OF VARIOUS DISEASES/CONDITIONS IN PATIENTS NOT TREATED WITH A P2Y12 PLATELET INHIBITOR AND NOT GIVEN A GLYCOPROTEIN IIB/IIIA INHIBITOR ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,114,313

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9604795Dec 20, 1996
PCT Information
PCT FiledDecember 11, 1997PCT Application Number:PCT/SE97/02068
PCT Publication Date:July 02, 1998PCT Publication Number: WO98/28009

International Family Members for US Patent 6,114,313

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 1121875 ➤ Try a Free Trial
Czech Republic 9902201 ➤ Try a Free Trial
Czech Republic 300635 ➤ Try a Free Trial
Germany 69714616 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
McKesson
Citi
Julphar
Argus Health
AstraZeneca
Chinese Patent Office
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.